Intercure Ltd.

Intercure Ltd.

Intercure Ltd. was founded as a publicly traded investment vehicle on the Tel Aviv Stock Exchange. It is linked to Israeli cannabis entrepreneur and principal Dov (Dudi) Shany, who has served as Chairman. The firm's controlling shareholder structure and board composition reflect typical family-office patterns, though the company's public listing adds regulatory transparency. Intercure focuses on the medical cannabis sector via Canndoc Ltd., a licensed producer in Israel and Canada. The firm has invested in cultivation, production, and distribution infrastructure. Its asset-class mix is narrowly concentrated in healthcare and specialty pharmaceutical operations, with a geographic footprint spanning Israel and Canada (per public filings). The firm's public listing on the Tel Aviv Stock Exchange means its financial disclosures offer rare granularity for a family-office-linked entity. Recent activity includes regulatory filings and ongoing operations in the medical cannabis space (per public filings). Intercure's structural differentiator is its status as a publicly traded family-office holding company, a governance model uncommon among single-family offices. This structure provides external oversight and liquidity options while maintaining concentrated family control.